Robert R. Bonczek
Director of Finance/CFO at Medblue Incubator, Inc.
Profile
Robert R.
Bonczek is currently the Director at Senex Biotechnology, Inc., President & Director at AspenTree Capital Corp., Director at The University of Texas at Austin, Board of Director at K2 Pure Solutions, Inc., Board of Director at NeurOp, Inc., Board of Director at Cellective BioTherapy, Inc., Board of Director at Istari Oncology, Inc., Operating Partner at Centre Partners Management LLC, and President & Chief Financial Officer at Medblue Incubator, Inc. Previously, he held positions as Chief Counsel, Worldwide Director-Safety & Health at EIDP, Inc., President, CFO, Director & General Counsel at B3 Bio, Inc., Director at Deep Blue Medical Advances, Inc., Chief Financial Officer & General Counsel at Trimeris, Inc., Legal Consultant at Wilmer Cutler Pickering Hale & Dorr LLP, and Consultant at Donaldson, Lufkin & Jenrette International.
He obtained his undergraduate and graduate degrees from The University of North Carolina at Charlotte and his MBA from The Wharton School of the University of Pennsylvania.
Robert R. Bonczek active positions
| Companies | Position | Start |
|---|---|---|
NeurOp, Inc.
 NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Director/Board Member | - |
AspenTree Capital Corp.
 AspenTree Capital Corp. Investment ManagersFinance AspenTree Capital Corp. provides investment advice. The private company is based in Durham, NC. | President | - |
K2 Pure Solutions, Inc.
 K2 Pure Solutions, Inc. Household/Personal CareConsumer Non-Durables K2 Pure Solutions, Inc. manufactures personal care and household cleaning products. It provides mitigate the potential environmental, security and operational risks associated with the transport of chlorine for water treatment and other industries by producing exceptionally pure bleach, caustic soda and other chlor-alkali related products using only salt, water and electricity in the most economically viable manner. The company was founded by David Cynamon and Howard Brodie and is headquartered in Toronto, Canada. | Director/Board Member | - |
| The University of Texas at Austin | Director/Board Member | - |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Director/Board Member | - |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | - |
| Medblue Incubator, Inc. | Director of Finance/CFO | - |
Cellective BioTherapy, Inc.
 Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC. | Director/Board Member | - |
Centre Partners Management LLC
 Centre Partners Management LLC Investment ManagersFinance Centre Partners Management LLC (Centre Partners) is a private equity firm founded in 1986 by Lester Pollack. The firm is headquartered in New York with additional offices in Los Angeles. | Private Equity Investor | - |
Former positions of Robert R. Bonczek
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░ ░ ░░ ░░░░ ░░ ░░░░░░░ ░░░ ░░ | ░░░░░░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Robert R. Bonczek
| The University of North Carolina at Charlotte | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Centre Partners Management LLC
Centre Partners Management LLC Investment ManagersFinance Centre Partners Management LLC (Centre Partners) is a private equity firm founded in 1986 by Lester Pollack. The firm is headquartered in New York with additional offices in Los Angeles. | Finance |
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Senex Biotechnology, Inc. is a drug discovery and development company focused on oncology therapeutics. The company was founded by Igor B. Roninson and is headquartered in Columbia, SC. | Health Technology |
AspenTree Capital Corp.
AspenTree Capital Corp. Investment ManagersFinance AspenTree Capital Corp. provides investment advice. The private company is based in Durham, NC. | Finance |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
| Donaldson, Lufkin & Jenrette International | Finance |
K2 Pure Solutions, Inc.
K2 Pure Solutions, Inc. Household/Personal CareConsumer Non-Durables K2 Pure Solutions, Inc. manufactures personal care and household cleaning products. It provides mitigate the potential environmental, security and operational risks associated with the transport of chlorine for water treatment and other industries by producing exceptionally pure bleach, caustic soda and other chlor-alkali related products using only salt, water and electricity in the most economically viable manner. The company was founded by David Cynamon and Howard Brodie and is headquartered in Toronto, Canada. | Consumer Non-Durables |
NeurOp, Inc.
NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Health Technology |
| B3 Bio, Inc. | |
Cellective BioTherapy, Inc.
Cellective BioTherapy, Inc. Pharmaceuticals: MajorHealth Technology Cellective BioTherapy, Inc. engages in the research and development of novel cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity, and immunodeficiency. Its proprietary pipeline and technology platform focuses on the unique aspects of B cell biology that are involved in regulating a variety of autoimmune diseases and inflammatory immune responses. The company was founded by Thomas F. Tedder in 2015 and is headquartered in Durham, NC. | Health Technology |
| Medblue Incubator, Inc. | |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
Deep Blue Medical Advances, Inc.
 Deep Blue Medical Advances, Inc. Medical SpecialtiesHealth Technology Deep Blue Medical Advances, Inc. operates as a biotechnology firm. It offers t-line mesh and anchor clips solutions. The company was founded by Howard Levinson and Ken Gall in March 2015 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Robert R. Bonczek
